Alto Solutions Patents – Key Insights and Stats

Alto Solutions has a total of 41 patents globally, out of which 9 have been granted. The United States of America is where Alto Solutions has filed the maximum number of patents, followed by Japan and China. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Alto Solutions.

Alto Solutions was founded in 2009 by Eric Satz. Alto Solutions develops software to manage investment and retirement assets. The Company offers platform that provide users with a simple interface to set up, invest with, and manage a diversified portfolio of alternative assets in start-ups, growth companies, real estate, loans, and digital assets.

Do read about some of the most popular patents of Alto Solutions which have been covered by us in this article and also you can find Alto Solutions patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Alto Solutions patent portfolio.

How many patents does Alto Solutions have?

Alto Solutions has a total of 41 patents globally. These patents belong to 3 unique patent families. Out of 41 patents, 1 patents are active.

How Many Patents did Alto Solutions File Every Year?

Alto Solutions Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAlto Solutions Applications FiledAlto Solutions Patents Granted
20041
20057
200616
20076
20081
201011
201212
201342
201422
201512
20161

How many Alto Solutions patents are Alive/Dead?

Worldwide Patents

Alto Solutions Patent Portfolio

How Many Patents did Alto Solutions File in Different Countries?

Alto Solutions Worldwide Patent Filing

Countries in which Alto Solutions Filed Patents

CountryPatent
United States of America12
Japan8
China6
Europe5
Canada4
India2

Where are Research Centers of Alto Solutions Patents Located?

The Research Center of Alto Solutions Patents is the United States of America.

10 Best Alto Solutions Patents

US20090099060A1 is the most popular patent in the Alto Solutions portfolio. It has received 10 citations so far from companies.

Below is the list of 10 most cited patents of Alto Solutions:

Publication NumberCitation Count
US20090099060A110
US20090203636A17
US20050113324A15
CN101588805A5
US8097595B24
US7741296B23
US8778906B23
CN101443021A3
CN101193643A3
CN1925750A3

What Percentage of Alto Solutions US Patent Applications were Granted?

Alto Solutions (Excluding its subsidiaries) has filed 1 patent application at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100%.

Below are the key stats of Alto Solutions patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Alto Solutions?

Law FirmTotal ApplicationsSuccess Rate
Wilson Sonsini Goodrich & Rosati1100%

List of Alto Solutions

Alto Solutions PatentsTitle
US8609623B2Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer
US8580753B2Modulation of telomere length in telomerase positive cells and cancer therapy
US8097595B2Modulation of telomere length in telomerase positive cells and cancer therapy
US7741296B2Modulation of telomere length in telomerase positive cells and cancer therapy
US9078901B2Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer
US8778906B2Modulation of line-1 reverse transcriptase
US20150094215A1Modulation of line-1 reverse transcriptase
US20050113324A1Modulation of line-1 reverse transcriptase
US20160000937A1Modulation of telomere length in telomerase positive cells and cancer therapy
US20140065072A1Modulation of Telomere Length in Telomerase Positive Cells and Cancer Therapy
US20090203636A1Prevention and Treatment of Cancer and Other Diseases
US20090099060A1Modulation of line-1 reverse transcriptase
EP2623105A3Modulation of line-1 reverse transcriptase
EP1885370A4Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer
EP1868615A4Modulation of telomere length in telomerase positive cells and cancer therapy
EP1713337A4Modulation of line-1 reverse transcriptase
EP2001488A4Prevention and treatment of cancer and other diseases
CN104997783AModulation of telomere length in telomerase positive cells and cancer therapy
CN104906105APharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer
CN101588805APharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer
CN101443021APrevention and treatment of cancer and other diseases
CN101193643AModulation of telomere length in telomerase positive cells and cancer therapy
CN1925750AModulation of LINE-1 reverse transcriptase
WO2006125166A9Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer
WO2007106561A3Prevention and treatment of cancer and other diseases
WO2006104975A2Modulation of telomere length in telomerase positive cells and cancer therapy
WO2005069880A3Modulation of line-1 reverse transcriptase
CA2602562CModulation of telomere length in telomerase positive cells and cancer therapy
CA2644297A1Prevention and treatment of cancer and other diseases
CA2609303A1Pharmacological modulation of telomere length in cancer cells for prevention and treatment of cancer
CA2553265A1Modulation of line-1 reverse transcriptase
JP5571947B2Prevention and treatment of cancer and other diseases
JP5032129B2Line-1 modulation of the reverse transcriptase
JP2016175917APrevention and treatment of cancer and other diseases
JP2014144962A5Prevention and treatment of cancer and other disease
JP2013224953A5Modulation of telomere length in telomerase positive cells and cancer therapy
JP2013166787AUse of composition for prevention and treatment of cancer
JP2008545658AFor the prevention and treatment of cancer, pharmacological modulation of telomere length in cancer cells
JP2008536822ARegulation of telomere length and cancer therapy in telomerase-positive cells
IN2218KOLNP2006Amodulation of line-1 reverse transcriptase
INPCT2006KOL02218AModulation of line-1 reverse transcriptase

What are Alto Solutions key innovation segments?

What Technologies are Covered by Alto Solutions?

The chart below distributes patents filed by Alto Solutions in different countries on the basis of the technology protected in patents. It also represents the markets where Alto Solutions thinks it’s important to protect particular technology inventions.

R&D Focus: How has Alto Solutionssearch focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Alto Solutions?

Updated on October 10, 2022

Was this article helpful?

Leave a Comment